Bristol-Myers says diabetes drug meets study goal

Published September 21, 2010

Bristol-Myers says diabetes drug meets study goal
(AP:NEW YORK) The drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC said Monday that their experimental diabetes drug dapagliflozin met its goal in a clinical trial, as the drug was more effective than an older treatment at reducing blood sugar levels.
Read more on INO News

Community drug take-back set for Sept. 25
The Bolivar Police Department and the Drug Enforcement Agency will hold a drug take-back from 10 a.m. to 2 p.m. Saturday, Sept. 25, at Southwest Electric.
Read more on Bolivar Herald-Free Press

U.S. panel backs Boehringer drug to reduce strokes
SILVER SPRING, Maryland (Reuters) – A new blood-thinning drug moved closer to U.S. approval on Monday, leading a pack of stroke-fighting medicines vying to compete in an estimated $ 10 billion a year market.
Read more on Reuters